Evidence map›Paper›PMID 29416669›Full record

ArticleOncotarget2018

Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients.

Lehui Du, Wei Yu, Xiangkun Dai, Nana Zhao, Xiang Huang, Fang Tong, Fang Liu, Yurong Huang, Zhongjian Ju, Wei Yang and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Bioscience reports · 2018
    Pooled it
  2. Article
  3. Article
  4. GSTP1 as a novel target in radiation induced lung injury.Journal of translational medicine · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Lehui DuDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Wei YuDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Xiangkun DaiDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Nana ZhaoDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Xiang HuangDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Fang TongDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Fang LiuDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Yurong HuangDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Zhongjian JuDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Wei YangDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Xiaohu CongDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Chuanbin XieDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Xiaoliang LiuDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Lanqing LiangDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Yanan HanDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Baolin QuDepartment of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 149 lung cancer patients were recruited to receive intensity modulated radiation therapy (IMRT). The association of developing radiation pneumonitis (RP) with genetic polymorphism was evaluated. The risks of four polymorphic sites in three DNA repair related genes (ERCC1, rs116615:T354C and rs3212986:C1516A; ERCC2, rs13181:A2251C; XRCC1, rs25487:A1196G) for developing grade ≥ 2 RP were assessed respectively. It was observed that ERCC1 T354C SNP had a significant effect on the development of grade ≥ 2 RP (CT/TT vs. CC, adjusted HR = 0.517, 95% CI, 0.285-0.939; adjusted

Indexed as

ERCC1ERCC2lung cancerradiation pneumonitisXRCC1

Identifiers

PMID29416669
PMCPMC5787526
OpenAlexW2774692076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.